With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...
The MiniMed 780G device is equipped with algorithms that can automatically adjust a wearer’s insulin dosages as necessary. It makes those decisions based on readings wirelessly transmitted from ...
Medtronic's MiniMed 780G diabetes management system is equipped with a new and improved version of its SmartGuard technology, featuring an algorithm that can automatically deliver correction bolus ...
BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE)-- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the ...
Medtronic plc MDT recently achieved the CE Mark for the MiniMed 780G system with Simplera Sync, a disposable, all-in-one continuous glucose monitor (CGM) that does not require any fingersticks or over ...
MiniMed automated insulin delivery and smart MDI systems can now be paired with Instinct and Instinct Go, made by Abbott, the smallest, longest-wear sensors in the company's portfolio "People with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Credit: Getty Images. The first shipments of the MiniMed 780G system are expected this summer with preorders beginning on May 15, 2023. The Food and Drug Administration (FDA) has approved the ...
Medtronic has commercially launched its MiniMed 780G system in the US, now integrated with Abbott’s Instinct sensor. The Instinct sensor utilises Abbott’s continuous glucose monitoring (CGM) ...
Medtronic has reported three milestones in the US, expanding access to its MiniMed 780G insulin delivery system for individuals with type 1 diabetes (T1D) and insulin-requiring type 2 diabetes (T2D).
A first-of-its-kind meta-analysis comparing multiple automated insulin delivery (AID) systems in people with type 1 diabetes has found that Medtronic's MiniMed 780G achieved the highest time in target ...
The FDA has approved Medtronic’s MiniMed 780G automated insulin delivery (AID) system for use in type 2 diabetes (T2D). At the same time, FDA also cleared the MiniMed SmartGuard algorithm as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results